Product logins

Find logins to all Clarivate products below.


Interventional Oncology Devices | Market Insights | Latin America (Supplemental) | 2021

Although the Latin American interventional oncology device market will be hindered in the immediate term by the impact of the COVID-19 pandemic, the market will resume moderate growth once the market recovers, driven by an increasing patient population, adoption of premium-priced devices, and the introduction of new devices in the countries covered. However, cost constraints in the region’s publicly funded health care systems will limit the pace of revenue expansion.

This Medtech 360 Report provides high-level market metrics for interventional oncology devices in the Latin American region, including country-level data for major countries and aggregate data for the rest of Latin America, across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gynecological Devices – Market Insights – Latin America
The Latin American gynecological device market will experience modest growth over the forecast period, driven primarily by increasing awareness of gynecological health and available treatment…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market is projected to experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Latin America
The Latin American GI endoscopy devices market is projected to grow moderately through 2034, driven by ongoing innovation in both diagnostic and interventional applications of GI endoscopy…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…